glp 1 for cardiovascular GLP-1 Receptor Agonists Reduce Adverse Outcomes, Improve Survival The cardiovascular effects of GLP-1

is NOT a licensed pharmacy in any state and does not provide pharmacy services as defined by state Boards of Pharmacy

doi: 10.1002/art.40406 69 BlackmoreDLiLWangNMaksymowychWYacyshynESiddiqiZAet al

IL-4 and IL-13 up-regulate intestinal trefoil factor expression: requirement for STAT6 and de novo protein synthesis

Magnesium: the overlooked electrolyte in blood cancers

Senolytics decrease senescent cells in humans: preliminary report from a clinical trial of Dasatinib plus quercetin in individuals with diabetic kidney disease

doi: 10.1016/S0140-6736(18)30480-X 3 FranciscoVPinoJGonzlez-GayMLagoFKarppinenJTervonenOet al